Monika Schäfer-Korting
Monika Schäfer-Korting is a renowned pharmacologist and toxicologist from Germany. She is known for her significant contributions to the field of pharmacology, particularly in the area of dermatopharmacology and toxicology.
Early Life and Education[edit | edit source]
Monika Schäfer-Korting was born in Germany. She pursued her studies in pharmacy at the University of Bonn, where she received her Pharmaceutical State Examination in 1972. She then went on to earn her PhD in pharmacology from the same university in 1975.
Career[edit | edit source]
After completing her PhD, Schäfer-Korting began her career as a research assistant at the Institute of Pharmacology at the University of Bonn. In 1983, she qualified as a university lecturer in pharmacology and toxicology.
In 1990, she was appointed as a full professor at the Free University of Berlin, where she served as the head of the Department of Pharmacology and Toxicology. Her research primarily focused on dermatopharmacology and toxicology, with a particular interest in the development of nanoparticles for drug delivery.
Contributions to Pharmacology[edit | edit source]
Schäfer-Korting has made significant contributions to the field of pharmacology. Her research has led to advancements in the understanding of drug delivery systems, particularly in the use of nanoparticles for drug delivery in dermatology.
She has also contributed to the development of in vitro models for toxicology testing, which have been instrumental in reducing the need for animal testing in the field of pharmacology.
Awards and Recognition[edit | edit source]
Over the course of her career, Schäfer-Korting has received numerous awards and recognition for her contributions to pharmacology and toxicology. These include the Paul Ehrlich and Ludwig Darmstaedter Prize for her research in dermatopharmacology.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
